Your browser is no longer supported. Please, upgrade your browser.
XLV Health Care Select Sector SPDR ETF daily Stock Chart
Health Care Select Sector SPDR ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-1.72%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-2.62%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter3.05%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio3.80 Perf Half Y9.07%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year3.58%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range62.21 - 76.00 Perf YTD2.44%
Dividend1.05 P/FCF- EPS past 5Y- ROI- 52W High-3.64% Beta-
Dividend %1.43% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low17.72% ATR0.63
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)41.07 Volatility1.17% 0.79%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.86 Prev Close73.07
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume8.57M Price73.23
Recom- SMA20-1.77% SMA50-0.35% SMA2004.64% Volume7,364,217 Change0.22%
Aug-29-16 02:03PM  US health care system needs more transparency: Pro
01:09PM  EpiPen as metaphor for broken health care system: Brill
12:26PM  Healthcare's best bets following generic EpiPen
11:05AM  A Look at Allergans Growth Pharma Model
10:05AM  How Allergan Is Still Benefiting from Actavis Deal
08:05AM  What Investors Should Know about the Pfizer-Anacor Deal
Aug-26-16 08:05AM  Third Point Lowered Its Position in Dow Chemical
Aug-25-16 03:19PM  Janus Capital Increased Position in Microsoft in 2Q16
08:30AM  Mylan stock set to snap four-day losing streak at MarketWatch
Aug-23-16 04:02PM  Best ETFs: Sector Funds at Forbes
03:04PM  How AbbVie Expects Risankizumab to Be a Transformative Therapy
02:00PM  Return Analysis: Health Care Select Sector SPDR (XLV) at Investopedia
12:27PM  An Appealing, Cost-Efficient Healthcare ETF
08:16AM  It Could Be An Interesting Ride For Healthcare ETFs
Aug-22-16 12:01PM  ETFs in Focus on Pfizer's Medivation Acquisition
11:05AM  How Did Bristol-Myers Squibbs Virology Segment Perform?
Aug-18-16 11:04AM  Mylan Expects to Be a Dominant Player in the Respiratory Market
Aug-17-16 03:06PM  Troubled drug company Valeant handed second upgrade of the week at MarketWatch
12:02PM  Brean Downgrades The Healthcare Sector On Technical Indicators
09:04AM  How Did Mercks Animal Health Segment Perform?
08:58AM  Valeant's stock soars after Morgan Stanley analyst turns bullish at MarketWatch
06:46AM  Healthcare Investors May Be Pricing In A Clinton Victory
04:58AM  Will the Cyclical Sector Outperform the Defensive Sector?
Aug-16-16 12:29PM  According to Janus, These Sectors Are Immune to Rising Inflation
05:52AM  Market melt-up play: Health care
Aug-15-16 11:05AM  Revlimid Is Expected to Become a Major Lymphoma Drug by 2020
08:45AM  Trader buys time for rally in health care
Aug-11-16 12:28PM  Valeant sinks on criminal probe
07:32AM  Valeants volatile shares are spooky how about trying its bonds instead? at MarketWatch
Aug-10-16 09:04AM  Becton Dickinsons Updated Guidance for 2016
08:02AM  S&P 500 over & underweights
Aug-09-16 12:00PM  Buy Mylan, Ride the Momentum
10:26AM  Changes to Richard Bernstein Advisors US Equities in 2016
Aug-08-16 05:46PM  How Did Regeneron Perform in 2Q16?
10:45AM  Sector ETFs: Selling into Upside Breakouts?
10:00AM  Bristol-Myers' stock extends slide after downgrade, Merck upgraded at MarketWatch
09:55AM  Non-Farm Payroll Steadies after 2 Months of Data Abberation
07:54AM  Bob Doll's top sector plays
Aug-05-16 09:04AM  How Elanco, Eli Lillys Animal Health Segment, Performed in 2Q
Aug-03-16 09:55AM  Pfizer: Five Years is a Long Time to Wait for Nothing at
Aug-02-16 02:25PM  361 Capital Weekly Research Briefing: Time to Separate the Wheat from the Chaff...
12:26PM  Barron's #1 advisor on Fed's next move
12:18PM  Is an August correction coming?
11:28AM  Buy Pfizer's Stock for Healthy Long-Term Gains
Aug-01-16 01:45PM  Revenue recession could finally be over at MarketWatch
11:06AM  C.R. Bards New Treatments for Hernia Are Key Growth Drivers
11:04AM  Gilead Continued Share Buybacks, Dividend Payouts in 2Q16
09:18AM  GICS Sector ETFs: Why Were Seeing Brexit-Style Outflows
09:09AM  These Drugs Were Key Growth Drivers for Amgens Revenue in 2Q16
Jul-29-16 11:36AM  Buy Merck on Near-Term Weakness
07:40AM  Why some see unloved health-care stocks as a screaming buy at MarketWatch
07:15AM  Beyond Merck's yield is value: Pro
Jul-28-16 09:07AM  What Drove Edwards Lifesciences THVT Revenues in 2Q16?
09:07AM  Mercks 2Q16 Estimates: Expected Growth Contributors
Jul-27-16 11:06AM  Biogen Misses EndPoints in Synergy Trial for Opicinumab
11:04AM  What Is Johnson & Johnsons Valuation?
09:12AM  What to Expect from Becton, Dickinson and Company in Fiscal 3Q16
09:10AM  Is Zimmer Biomet Expected to Post Revenue Growth for 2Q16?
08:16AM  Edwards Lifesciences 2Q16 Earnings Surpass Analyst Estimates
Jul-26-16 11:18AM  Analysts Take on Zimmer Biomet Holdings before 2Q16 Earnings
09:44AM  Buy Express Scripts at $73, Not Near $77
09:08AM  Whats Boosted Investors Confidence in Biogen in 2016?
Jul-25-16 01:32PM  Thermo Fisher Scientifics 2Q16 Revenues: Whats in Store?
09:49AM  Sector Flows: Should Equity Bulls Be Worried?
09:30AM  The Zacks Analyst Blog Highlights: Health Care Select Sector SPDR Fund, iShares U.S. Consumer Services ETF, First Trust Utilities AlphaDEX Fund and PowerShares S&P SmallCap Utilities Portfolio ETF
09:05AM  Orkambi Launch Impacts Vertex Pharmaceuticalss Major Revenue Contributor
Jul-22-16 02:04PM  GILD Developing Next Generation HCV Drugs to Remain Competitive
01:28PM  St. Jude Medical Gets Hold Rating from 96% of Analysts
01:16PM  Is Vertex Pharmaceuticals Exposed to Drug Pricing Risks?
01:16PM  How Alexion Plans to Fuel Strensiq Sales
01:14PM  Why Johnson & Johnsons 2Q16 Profits Fell by 11.5%
01:07PM  What Are Lillys 2Q16 Estimates and Expectations for Elanco?
07:29AM  Abbotts 2Q16 Earnings Propelled by Impressive Sales Growth
05:42AM  Summer's top summer sector: Health care
Jul-21-16 02:00PM  3 Healthcare ETFs to Buy as JNJ Beats Q2 Earnings
08:16AM  4 Healthcare Mutual Funds to Buy on Bright Prospects
Jul-20-16 12:04PM  Behind the bull market
10:13AM  Richard Bernstein on Profits Recession and Portfolio Positioning
Jul-19-16 06:20PM  Dow ETF Notches Fresh Closing High As Blue Chip Stocks Take The Reins
02:24PM  Inside Bill Ackmans Current Stance and View of His Holdings
08:58AM  How to Profit From Abbott Labs
Jul-15-16 01:19PM  For this rally to continue, there must be a change in leadership at MarketWatch
10:29AM  Analysts Ratings of St. Jude Medical before 2Q16 Results
04:23AM  Analysts Latest Recommendations for Intuitive Surgical
Jul-14-16 08:41PM  Abbott Laboratories: Analyst Recommendations before 2Q16 Results
11:56AM  Could the Dow Jump Up Another 400 Points by Year-End?
10:04AM  What Do Analysts Recommend for UNH ahead of 2Q16 Earnings?
Jul-13-16 09:07AM  Will June Jobs Report Speed Up the Feds Next Rate Hike?
Jul-12-16 09:06PM  Regenerons Robust Pipeline
08:06PM  How Are Thermo Fishers Commercial Capabilities Driving Its Share Gains?
06:06PM  What Are Varians Key Initiatives for the Particle Therapy Business?
Jul-11-16 11:42AM  GICS Sectors: Investors Err on the Side of Caution
07:03AM  Does the Rebound in Non-Farm Payrolls Favor a Rate Hike?
01:05AM  A Look at Alexions 2016 Guidance
Jul-09-16 07:05AM  Are Stocks Ready To Rocket Higher?
Jul-08-16 04:35PM  Medtronics Heartware Acquisition: Portfolio Impact
Jul-07-16 05:26PM  Humana stock tumbles nearly 10% steepest daily drop in 4 years at MarketWatch
Jul-06-16 11:50AM  The Driverless City
09:23AM  Health Care Stocks Are Quietly Moving Higher
Jul-05-16 03:06PM  Will General Electrics Healthcare Segment Score in 2Q16?
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.